Drug intelligence / Profile preview

gabapentin + oxycodone

Development stage
Phase 4
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Gabapentin + oxycodone is a combination therapy used primarily for the management of moderate to severe pain, especially when pain has both neuropathic and nociceptive components. Gabapentin is an anticonvulsant that modulates nerve signaling to reduce neuropathic pain, while oxycodone is an opioid analgesic that acts on mu, kappa, and delta opioid receptors in the central nervous system to alter the perception of pain. This combination can provide enhanced analgesia compared to either drug alone and may allow for lower doses of opioids, reducing some opioid-related side effects such as nausea, vomiting, and constipation. However, concurrent use increases risks such as sedation and respiratory depression; therefore, close monitoring is required[1][2][5][8].

Other names
gabapentin and oxycodoneoxycodone and gabapentin
02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)α2δ (Voltage-gated calcium channel alpha-2-delta subunit)

Beyond the preview

Go deeper on gabapentin + oxycodone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gabapentin + oxycodone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call